News for 'drug regulations'

Govt allows round-the-clock vaccination against COVID-19

Govt allows round-the-clock vaccination against COVID-19

Rediff.com4 Mar 2021

Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.

Centre waives off customs duty on oxygen, vaccines

Centre waives off customs duty on oxygen, vaccines

Rediff.com24 Apr 2021

This will boost availability of these items as well as make them cheaper, it said, adding that Modi also directed the revenue department to ensure seamless and quick custom clearance of such equipment.

Markets extend losses on geopolitical concerns; Nifty ends below 9,200

Markets extend losses on geopolitical concerns; Nifty ends below 9,200

Rediff.com7 Apr 2017

The BSE Midcap and the BSE Smallcap indices pared all intraday gains to end 0.3% and 0.5% lower

Company Watch: Emami, Shriram Transport, Lupin

Company Watch: Emami, Shriram Transport, Lupin

Rediff.com8 Feb 2021

Check out some of the stocks that will react on the basis of their numbers in the near term.

Received Both Doses? Be Careful Please

Received Both Doses? Be Careful Please

Rediff.com23 Jul 2021

'You will still want to take all the necessary precautions, which is the right thing to do.'

Maha curbs: Fruit vendors, security services exempted

Maha curbs: Fruit vendors, security services exempted

Rediff.com6 Apr 2021

The strict curbs, including a curfew from 8 pm till 7 am, and prohibitory orders during the daytime on weekdays came into force from Monday in the state.

Why govt has failed to check the spread of coronavirus in India

Why govt has failed to check the spread of coronavirus in India

Rediff.com23 Mar 2020

An overarching law governing public healthcare is a glaring gap in India's fight against the COVID-19 pandemic. In India it is left to individuals to quarantine themselves voluntarily. Moreover, the 123-year old The Epidemic Diseases Act, 1897, governs healthcare emergencies in India.

Is Tourism Destroying Goa?

Is Tourism Destroying Goa?

Rediff.com24 Feb 2023

Poor governance and mediocre short-sighted politics are destroying the paradise that Goa was as its environment, water table, culture and way of life is drastically threatened by tourism and migration, points out Ramesh Menon.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

Maneka Gandhi suggests legalising marijuana for medical purposes

Maneka Gandhi suggests legalising marijuana for medical purposes

Rediff.com30 Jul 2017

She also suggested exploring the possibility of setting up de-addiction centres near these railway stations.

Tandav row: Govt seeks Amazon Prime's reply

Tandav row: Govt seeks Amazon Prime's reply

Rediff.com18 Jan 2021

Bharatiya Janata Party MP Manoj Kotak has written to Information and Broadcasting Minister Prakash Javadekar seeking a ban on Amazon Prime Video's series Tandav for allegedly ridiculing Hindu deities.

'India among top countries in illegal wildlife trade'

'India among top countries in illegal wildlife trade'

Rediff.com14 Jun 2022

'With just 2.4 per cent of global landmass, India houses six to eight per cent of planetary biodiversity and hence is a prime target of wildlife criminals.'

Can't throw out plea of doctors' associations against Ramdev: HC

Can't throw out plea of doctors' associations against Ramdev: HC

Rediff.com25 Oct 2021

"The allegations may be right or maybe wrong. He may say he did not say any such thing... It needs to be looked into," said the judge.

USFDA issues import alert on Ranbaxy's Mohali plant

USFDA issues import alert on Ranbaxy's Mohali plant

Rediff.com16 Sep 2013

While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Rediff.com7 Aug 2021

"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID-19," tweeted the minister.

A pharmacy store in your pocket!

A pharmacy store in your pocket!

Rediff.com16 May 2016

1mg has made buying medicines easy and it aims to do more in online health care.

Want to make big money in stocks? Go contrarian

Want to make big money in stocks? Go contrarian

Rediff.com7 May 2018

Contrarian stocks can help investors generate much higher returns than buying shares of companies that have shown consistent high growth for years.

Sensex gains 65 points; Nifty ends above 8,100

Sensex gains 65 points; Nifty ends above 8,100

Rediff.com12 Sep 2014

The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.

Glenmark gets USFDA final nod for contraceptive tablets

Glenmark gets USFDA final nod for contraceptive tablets

Rediff.com15 Jun 2015

It is the generic version of Teva Women's Health's Seasonale tablets

What India is doing to contain coronavirus outbreak

What India is doing to contain coronavirus outbreak

Rediff.com18 Mar 2020

As the Indian Army reported its first case of the infection with a 34-year-old soldier testing positive in Leh, the Army said it has taken a series of precautionary measures to prevent the spread of coronavirus among the forces such as checking flu symptoms among soldiers on their return from leave and cancelling non-essential travel, conferences and recruitment drives.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Why I don't advise clients on cryptos

Why I don't advise clients on cryptos

Rediff.com17 Nov 2021

Risk is difficult to evaluate, warns Harsh Roongta.

Drug-testing lab will be operational for Olympics: Rio chief

Drug-testing lab will be operational for Olympics: Rio chief

Rediff.com4 Mar 2016

The anti-doping laboratory that will test athletes during this year's Olympic Games will be fully WADA compliant by this month's deadline, Rio organising committee president Carlos Nuzman said on Thursday.

Ranbaxy gets US nod to sell Alzheimer's generic

Ranbaxy gets US nod to sell Alzheimer's generic

Rediff.com22 Sep 2010

India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

Terror strikes Lahore's Mall Road; senior cops among 13 dead

Terror strikes Lahore's Mall Road; senior cops among 13 dead

Rediff.com13 Feb 2017

Senior police officers were among 13 people killed on Monday when a Taliban suicide bomber blew himself up targeting them during a protest rally outside Pakistan's Punjab assembly in Lahore that also wounded 60 others.

Ranbaxy launches Lipitor's generic version in US

Ranbaxy launches Lipitor's generic version in US

Rediff.com1 Dec 2011

The launch came after final approval from the US health regulator to manufacture the generic version of Lipitor at Ranbaxy's wholly owned Ohm Laboratories facility in New Brunswick, New Jersey, as well as market the product.

Can Ranbaxy recover from its US debacle?

Can Ranbaxy recover from its US debacle?

Rediff.com2 Feb 2012

USFDA consent decree reveals that firm will have to forego huge short-term opportunities for its generics.

Sensex ends 100 points higher after rupee, China shares rebound

Sensex ends 100 points higher after rupee, China shares rebound

Rediff.com19 Aug 2015

Bharti Airtel , RCom and Tata Communications ended down between 0.1-1%.

Ranbaxy settles case with USFDA, to pay $500 mn

Ranbaxy settles case with USFDA, to pay $500 mn

Rediff.com21 Dec 2011

Drug-maker Ranbaxy Laboratories on Wednesday said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to $500 million to settle a case lodged by the Department of Justice.

Markets end in the green ahead of F&O expiry

Markets end in the green ahead of F&O expiry

Rediff.com23 Nov 2016

Broader market outperformed the headline indices with BSE Midcap and Smallcap finishing the day 1.22%, and 1.54% higher, respectively

Manufacturing norms violated: USFDA slams Cadila

Manufacturing norms violated: USFDA slams Cadila

Rediff.com7 Jul 2011

The regulator has given the company 15 days to take corrective measures and report back to it.

Integration challenges: Sun Pharma's next hurdle

Integration challenges: Sun Pharma's next hurdle

Rediff.com23 Apr 2015

The challenge of merging Ranbaxy into the company has not been factored in.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Non Alcoholic Fatty Liver And Diabetes: What You Must Know

Non Alcoholic Fatty Liver And Diabetes: What You Must Know

Rediff.com27 Sep 2022

'We found that in fatty liver patients, something happens that blocks insulin secretion.'

Markets end in red; Lupin slumps 9%, ITC up 2%

Markets end in red; Lupin slumps 9%, ITC up 2%

Rediff.com20 May 2016

A mixed global trend and weakness in rupee influenced the sentiments during the day.

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

USFDA warns Aurobindo Pharma

USFDA warns Aurobindo Pharma

Rediff.com23 May 2011

Company had earlier received an import alert in February this year from the US Food and Drug Administration.

Boxing champ loses licence for promoting domestic abuse

Boxing champ loses licence for promoting domestic abuse

Rediff.com30 Mar 2020

WBO super middleweight champion Billy Joe Saunders apologised for his social media post on the weekend and then on Monday: 'I just want to say sorry again for everyone I've offended'.

Serum to double Covid vaccine output in 2022

Serum to double Covid vaccine output in 2022

Rediff.com13 Jul 2021

SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.